Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Literature
1.
Yang J, Tang S, Zhou Y, Qiu J, Zhang J, Zhu S, Lv Q. Prognostic implication of the primary tumor location in early-stage breast cancer: focus on lower inner zone. Breast Cancer. 2017;. doi:10.​1007/​s12282-017-0797-5 (Epub ahead of print).PubMedCentral
Metadata
Title
Questions about lower inner zone tumors in early-stage breast cancer
Author
Kadri Altundag
Publication date
01-11-2017
Publisher
Springer Japan
Published in
Breast Cancer / Issue 6/2017
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-017-0801-0

Other articles of this Issue 6/2017

Breast Cancer 6/2017 Go to the issue

Letter to the Editor

Robust predictive markers are needed for early detection of trastuzumab-related cardiac dysfunction in breast cancer

Original Article

High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients

Acknowledgment

Acknowledgement to reviewers 2017

Author's Reply

Uncertainties remain in the status of internal mammary lymph nodes in breast cancers located in lower inner zone

Original Article

Therapeutic alliance and treatment outcome in psychodynamic psychotherapy of depressed breast cancer patients: the same old story or different from other populations?

Letter to the Editor

Pure invasive lobular carcinoma versus mixed invasive lobular cancer and invasive ductal carcinoma: metastatic patterns differ?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits